Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediates.
Efficient iron-catalyzed synthesis of pyrrolo[1,2-a]indole alkaloids via C-H/N-H activation. Mild conditions, high yield, scalable process for pharma intermediates.
Patent CN112480015B details a novel Pd-catalyzed one-pot synthesis for 2-trifluoromethyl quinazolinones, offering significant cost reduction and supply chain advantages for pharmaceutical intermediates.
Novel copper-catalyzed route for polyfluoroalkyl indolines. Reduces cost vs palladium methods. High purity pharmaceutical intermediates available.
Patent CN102040564B reveals a safe, high-yield nucleophilic substitution route for 3-aminobenzo[d]isothiazole, offering significant cost reduction and supply chain stability for pharma manufacturing.
Patent CN113801050A reveals a copper-catalyzed method for highly functionalized beta-lactams, offering cost reduction in pharmaceutical intermediate manufacturing and scalable production.
Patent CN109134351B details a novel synthesis of S-3-(4-aminophenyl)piperidine with >99% ee, offering cost-effective scalability for PARP inhibitor manufacturing.
Novel Pd-catalyzed serial cyclization method offers high purity beta-halopyrroles with simplified supply chains and cost-effective manufacturing for global pharma.
Novel Fe(NO3)3 catalyzed method for gem-dinitro compounds. Safe, mild conditions for pharmaceutical intermediates. Cost-effective manufacturing solution.
Novel Pd-catalyzed synthesis offers high efficiency and cost reduction in pharmaceutical intermediate manufacturing for global supply chains.
Patent CN112125856A reveals a safe Pd-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN114195711B reveals efficient Pd-catalyzed carbonylation. Offers cost reduction in pharmaceutical intermediates manufacturing and reliable supply chain.
Novel Pd-catalyzed carbonylation method for indole and benzoxazine compounds offering significant cost reduction and enhanced supply chain reliability for global pharmaceutical intermediates.
Novel 5-step synthesis of Trilaciclib via CN114014864A. Offers high purity, mild conditions, and cost-effective manufacturing for global pharmaceutical supply chains.
Novel Pd-catalyzed synthesis offers cost reduction in pharmaceutical intermediate manufacturing with high purity and scalable supply chain reliability for global buyers.
Patent CN113735826B reveals palladium-catalyzed carbonylation for high-purity pharmaceutical intermediates with scalable cost reduction.
Novel Ag2O-promoted synthesis delivers high-purity imidazole intermediates. This cost-effective scalable process ensures robust supply chain stability for global pharmaceutical applications and drug development.
Novel metal-free route for 1,2,4-triazines offers significant cost reduction in API manufacturing and highly scalable production capabilities for global pharmaceutical supply chains.
Novel carbonylation route for pyrrol-2-one scaffolds offers high efficiency and substrate compatibility for pharmaceutical manufacturing.
Novel nickel-catalyzed method for alpha beta-unsaturated amides. Reduces toxicity and cost. Reliable pharmaceutical intermediates supplier for scale-up.